In Thursday's session, Ipca Labs, Ajanta Pharma emerged as top gainers on the Nifty Midcap 150 at 10:30 am. Ipca Labs was trading at Rs 1,515.00, a 3.77% gain. Ajanta Pharma was at Rs 2,771.80 with 1.96% increase. SRF at Rs 3,247.30 rose 1.7%, Oracle Fin Serv at Rs 8,922.00 gained 1.63% and Max Healthcare at Rs 1,275.30 increased by 1.59%.
Ipca Labs Financials:
The following table presents the consolidated quarterly financial performance of Ipca Labs:
| Heading | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Revenue | Rs 2,033.01 Crore | Rs 2,092.63 Crore | Rs 2,354.90 Crore | Rs 2,245.37 Crore | Rs 2,246.69 Crore |
| Net Profit | Rs 2.91 Crore | Rs 198.98 Crore | Rs 245.44 Crore | Rs 277.33 Crore | Rs 65.78 Crore |
| EPS | 2.35 | 7.58 | 9.05 | 9.78 | 2.67 |
The following table presents the consolidated yearly financial performance of Ipca Labs:
| Heading | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | Rs 5,419.99 Crore | Rs 5,829.79 Crore | Rs 6,244.32 Crore | Rs 7,705.04 Crore | Rs 8,939.59 Crore |
| Net Profit | Rs 1,148.84 Crore | Rs 910.95 Crore | Rs 491.93 Crore | Rs 529.21 Crore | Rs 787.53 Crore |
| EPS | 45.01 | 34.85 | 18.58 | 25.82 | 35.14 |
| BVPS | 371.79 | 219.51 | 233.16 | 304.57 | 273.88 |
| ROE | 24.24 | 16.09 | 8.06 | 8.64 | 10.61 |
| Debt to Equity | 0.05 | 0.14 | 0.25 | 0.22 | 0.19 |
Ajanta Pharma Financials:
The following table presents the consolidated quarterly financial performance of Ajanta Pharma:
| Heading | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Revenue | Rs 1,054.08 Crore | Rs 1,144.92 Crore | Rs 1,186.64 Crore | Rs 1,146.13 Crore | Rs 1,170.41 Crore |
| Net Profit | Rs 202.72 Crore | Rs 245.77 Crore | Rs 216.48 Crore | Rs 232.88 Crore | Rs 225.26 Crore |
| EPS | 16.10 | 19.54 | 17.27 | 18.60 | 18.00 |
The following table presents the consolidated yearly financial performance of Ajanta Pharma:
| Heading | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | Rs 2,889.69 Crore | Rs 3,340.99 Crore | Rs 3,742.64 Crore | Rs 4,208.71 Crore | Rs 4,648.10 Crore |
| Net Profit | Rs 653.87 Crore | Rs 712.68 Crore | Rs 587.98 Crore | Rs 816.17 Crore | Rs 920.39 Crore |
| EPS | 75.09 | 82.45 | 45.89 | 64.82 | 73.56 |
| BVPS | 344.52 | 380.24 | 268.14 | 282.34 | 302.38 |
| ROE | 21.82 | 21.83 | 17.35 | 22.87 | 24.28 |
| Debt to Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Ipca Laboratories Limited has announced Rs 2.00 dividend amount on 29 May, 2025 with effective date as 05 Aug, 2025. Ajanta Pharma has announced Rs 28.00 dividend amount on 25 Oct, 2024 with effective date as 06 Nov, 2024.
With Ipca Labs trading at Rs 1,515.00 and Ajanta Pharma at Rs 2,771.80, both stocks have demonstrated significant gains, positioning them as top performers within the Nifty Midcap 150 index.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
